Pharmanetics, Inc.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 19, 2002
Pharmanetics, Inc.
(Exact name of registrant as specified in its charter)
North Carolina
(State or other jurisdiction of incorporation)
| 0-25133
|
|
56-2098302
|
| (Commission file Number) |
|
(IRS Employer ID Number) |
9401 Globe Center Drive, Morrisville, North Carolina 27560
(Address of principal executive
offices) (Zip Code)
| Registrant’s telephone number, including area code |
|
919-582-2600 |
| |
|
|
NA
(Former name or former address, if changed since last report)
–MORE–
Item 5. Other Events.
On December 19, 2002, the Registrant issued the press release filed herewith as Exhibit 99.1.
Item 7. Exhibits
(c)
Exhibits
| Exhibit No.
|
|
|
| |
| 99.1 |
|
Press release issued on December 19, 2002. |
–MORE–
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
PHARMANETICS, INC. |
| |
| Date: December 19, 2002 |
|
|
|
/s/ JOHN P.
FUNKHOUSER
|
| |
|
|
|
John P. Funkhouser President and Chief Executive Officer |
–MORE–